GE HealthCare submits deep learning tech for FDA clearance
CleaRecon DL aims to improve cone-beam computed tomography image quality and will be available for GE HealthCare’s Allia ...
GE HealthCare寻求FDA批准AI增强CBCT技术
GE HealthCare全球介入业务总经理Arnaud Marie解释说，自然的身体运动和扫描中造影剂的分布历来会产生伪影，这给CBCT图像的清晰解读带来挑战。CleaRecon DL是GE HealthCare针对这一障碍的回应，旨在使医生和患者都能受益于先进的成像技术。
来自MSN6 个月
GE HealthCare and Medis partner on non-invasive coronary assessments
with GE HealthCare’s interventional cardiology portfolio around Allia Platform. The companies expect the collaboration to provide access to emerging technologies such as Medis QFR, as per the ...
MassDevice1 天
GE HealthCare submits CleaRecon DL to FDA
GE HealthCare (Nasdaq:GEHC) announced today that it submitted its CleaRecon DL technology for FDA 510(k) clearance.